GINA LAUGHLIN: Open Payments
NPI 1922363845 · LOUISVILLE, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$815 in 55 payments from 13 companies in 2025. Trend: 2023 $311 · 2024 $656 · 2025 $815
Food & beverage: $815
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 21 | $234 |
| Lilly USA, LLC | 10 | $169 |
| Exact Sciences Corporation | 6 | $93 |
| Novo Nordisk Inc | 5 | $80 |
| PFIZER INC. | 4 | $68 |
| Axsome Therapeutics, Inc. | 2 | $32 |
| Alnylam Pharmaceuticals Inc. | 1 | $27 |
| Astellas Pharma US Inc | 1 | $24 |
| Sumitomo Pharma America, Inc. | 1 | $22 |
| GlaxoSmithKline, LLC. | 1 | $18 |
Products named: VRAYLAR, MOUNJARO, Cologuard Collection Kit, Ozempic, PREVNAR 20, JARDIANCE, Auvelity, GIVLAARI.
Industry payments across KY — which companies pay providers there.
